The standardized extract of Ginkgo biloba, used for managing cardiovascular disease, improving blood oxygenation, reducing inflammation in colitis, and slowing the decline of brain function as we get older, seems now to reduce anxiety in people of all ages.
A new study (107 subjects) showed very significant improvement in the symptoms associated with "generalized anxiety disorder". The product used was EGb 761, the usual extract standardized to 24% ginkgo-flavone glycosides and 6% terpenoids. The dose was higher than what I often suggest, and the authors noticed a dose-dependent reduction in symptoms (they were giving 480mg and 240mg of extract daily).